Research Area

Study shows promise for iNKT cell platform to treat cancer (link is external)
Researchers from the School of Veterinary Medicine and Perelman School of Medicine have shown that invariant natural killer T cells from a healthy donor can persist in MHC-mismatched canines, demonstrating…

Research Brief
Translating Emerging Cancer Science into Effective Therapies Beyond being devoted companions, dogs share essential aspects of their biology with humans. While cancer scientists frequently use cell lines and rodent…

Penn Vet’s Dr. Nicola “Nicky” Mason Appears on 60 Minutes
The interview highlighted Dr. Mason’s role in leading clinical trials that evaluated a novel Listeria-based vaccine to treat pet dogs with osteosarcoma, a common canine bone cancer.